Composite primary outcome | ||
---|---|---|
Outcome | Measuring method | Description |
Non-elective hospitalisations or all-cause mortality | Recorded by the GP in the case report form (CRF) at FU1, FU2, T2 (final data analysis) | Hospitalisations: number of episodes (referral to any acute care facility, either emergency department or hospital; elicited by the GP, by any other physician or by the patient himself) Death: number of patients |
Secondary outcomes | ||
Outcome | Measuring method | Description |
All-cause mortality | All events were recorded by the GPs in the CRF at T0, FU1, FU2, T2 | Number of patients |
Non-elective hospital admissions | All events were recorded by the GPs in the CRF at T0, FU1, FU2, T2 | Number of episodes (see primary endpoint) |
Falls | All events were recorded by the GPs in the CRF at T0, FU1, FU2, T2 | Number of falls requiring medical care |
Fractures | All events were recorded by the GPs in the CRF at T0, FU1, FU2, T2 | Number of fractures occurred within the observation period |
Number of drug prescriptions | Recorded by the GPs in the CRF at T0, FU1, FU2, T2 | Total number of prescribed drugs |
Health-related quality of life | EQ-5D-5L and EQ-VAS [35] The questionnaire was handed out to the patients by the GPs at T0 and T2 (prior to / after the intervention) | - Five items addressing health-related QoL (mobility, self-care, usual activities, anxiety / depression, pain) and resulting in an index value (maximum = 1 = full health) - Visual analogue scale EQ-VAS (range 0–100) |
Affective status | 5-Item Geriatric Depression Scale (5-GDS) [36] The questionnaire was handed out to the patients by GPs at T0 and T2 | - Five items addressing satisfaction, tediousness, helplessness, social withdrawal, self-esteem - ≥2 points → presence of depressive symptoms (range 0–5) |
Cognitive performance | 6-Item Cognitive Impairment Test (6-CIT) [37] The questionnaire was handed out to the patients by GPs at T0 and T2 | - Six items evaluating cognitive function - ≥10 points → significant cognitive impairment (range 0–28) |